3.26
price up icon1.24%   0.04
after-market Dopo l'orario di chiusura: 3.18 -0.08 -2.45%
loading
Precedente Chiudi:
$3.22
Aprire:
$3.19
Volume 24 ore:
3.61M
Relative Volume:
0.30
Capitalizzazione di mercato:
$429.61M
Reddito:
-
Utile/perdita netta:
$-35.47M
Rapporto P/E:
-5.7193
EPS:
-0.57
Flusso di cassa netto:
$-124.27M
1 W Prestazione:
-7.39%
1M Prestazione:
+405.27%
6M Prestazione:
+89.53%
1 anno Prestazione:
+55.24%
Intervallo 1D:
Value
$3.06
$3.33
Intervallo di 1 settimana:
Value
$2.87
$3.56
Portata 52W:
Value
$0.4603
$7.13

Prokidney Corp Stock (PROK) Company Profile

Name
Nome
Prokidney Corp
Name
Telefono
336-999-7028
Name
Indirizzo
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Name
Dipendente
204
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-09
Name
Ultimi documenti SEC
Name
PROK's Discussions on Twitter

Confronta PROK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PROK
Prokidney Corp
3.26 429.61M 0 -35.47M -124.27M -0.57
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Prokidney Corp Stock (PROK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-30 Downgrade BofA Securities Neutral → Underperform
2024-09-30 Iniziato JP Morgan Neutral
2024-09-10 Iniziato Guggenheim Buy
2024-03-07 Ripresa Morgan Stanley Equal-Weight
2024-01-02 Downgrade BofA Securities Buy → Neutral
2023-07-25 Iniziato BTIG Research Buy
2022-12-21 Iniziato Jefferies Buy
2022-11-10 Iniziato Morgan Stanley Equal-Weight
2022-10-18 Iniziato UBS Buy
2022-10-14 Iniziato Citigroup Buy
2022-09-23 Iniziato BofA Securities Buy
2022-09-02 Iniziato Evercore ISI Outperform
Mostra tutto

Prokidney Corp Borsa (PROK) Ultime notizie

pulisher
12:15 PM

Prokidney’s REACT Study: A Promising Step for Kidney Disease Treatment - TipRanks

12:15 PM
pulisher
04:50 AM

Meet the Biotech Stock That Rocketed 775% Higher - AOL.com

04:50 AM
pulisher
Jul 23, 2025

Is ProKidney Corp. a good long term investmentGame-changing returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives ProKidney Corp. stock priceHigh-octane financial growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about ProKidney Corp. stockExplosive trading growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

ProKidney Corp (PROK) Completes Re-domestication to Delaware amid Kidney Therapy Advancement - MSN

Jul 23, 2025
pulisher
Jul 21, 2025

11 Best High Return Penny Stocks to Buy Now - Insider Monkey

Jul 21, 2025
pulisher
Jul 20, 2025

ProKidney Corp. Stock Analysis and ForecastDynamic profit expansion - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

JP Morgan Maintains a Neutral Stance on ProKidney Corp. (PROK) - MSN

Jul 20, 2025
pulisher
Jul 20, 2025

ProKidney Corp. (PROK): Navigating Clinical Pivotality and Market Volatility in the Race for a CKD Breakthrough - AInvest

Jul 20, 2025
pulisher
Jul 20, 2025

JP Morgan Maintains Neutral Stance on ProKidney Corp., Citing Extended Timeline for Key Data - AInvest

Jul 20, 2025
pulisher
Jul 19, 2025

New Strong Buy Stocks for July 17th - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

10 Hot Penny Stocks to Invest in Now - Insider Monkey

Jul 18, 2025
pulisher
Jul 18, 2025

ProKidney Shares Dip Following FDA Agreement on Rilparencel Approval Strategy - MSN

Jul 18, 2025
pulisher
Jul 17, 2025

PROKIDNEY CP (PROK) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy? - Mitrade

Jul 17, 2025
pulisher
Jul 17, 2025

Best Momentum Stocks to Buy for July 17th - Nasdaq

Jul 17, 2025
pulisher
Jul 17, 2025

PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

ProKidney gains pivotal therapy advancement step with FDA - Winston-Salem Journal

Jul 17, 2025
pulisher
Jul 16, 2025

ProKidney completes Delaware domestication and restructures corporate agreements By Investing.com - Investing.com Nigeria

Jul 16, 2025
pulisher
Jul 16, 2025

ProKidney completes Delaware domestication and restructures corporate agreements - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

Citi Maintains ProKidney(PROK.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛

Jul 16, 2025
pulisher
Jul 16, 2025

Will ProKidney’s Recent Surge Last? - StocksToTrade

Jul 16, 2025
pulisher
Jul 16, 2025

ProKidney’s Clinical Trials and Regulatory Developments Lead to Hold Rating Amid Uncertainty - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

ProKidney Corp. (PROK) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Jul 16, 2025
pulisher
Jul 16, 2025

ProKidney’s Hold Rating: Balancing FDA Alignment and Extended Approval Timeline - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

ProKidney’s Strategic FDA Alignment and Promising Clinical Data Drive Buy Rating - TipRanks

Jul 16, 2025
pulisher
Jul 15, 2025

ProKidney stock soars after FDA confirms accelerated approval pathway - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

ProKidney price target raised to $7 from $6 at Guggenheim - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

ProKidney’s Dramatic Shares Tumble - timothysykes.com

Jul 15, 2025
pulisher
Jul 15, 2025

Is ProKidney’s Slide a Buy Signal? - StocksToTrade

Jul 15, 2025
pulisher
Jul 15, 2025

ProKidney Shares Plummet Amid Downgrades - timothysykes.com

Jul 15, 2025
pulisher
Jul 15, 2025

UBS Initiates ProKidney(PROK.US) With Buy Rating, Announces Target Price $8 - 富途牛牛

Jul 15, 2025
pulisher
Jul 15, 2025

ProKidney Shares Surge in Early Trading On FDA Support for Kidney Drug Trial - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

ProKidney Stock Skyrockets: What Does This Mean? - StocksToTrade

Jul 15, 2025
pulisher
Jul 15, 2025

ProKidney, FDA align on accelerated approval pathway for Rilparencel - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

UBS Adjusts ProKidney Price Target to $8 From $4, Maintains Buy Rating - MarketScreener

Jul 15, 2025

Prokidney Corp Azioni (PROK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):